Hologic (HOLX) PT Boosted to $37 at Leerink Partners Amid 'Strong' Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Hologic (HOLX) Tops Q2 EPS by 2c, Raises FY15 Guidance
April 29, 2015 5:04 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $655.5 million versus the consensus estimate of $646.49 million.
Hologic sees FY2015 EPS of $1.57-$1.59, versus prior guidance of $1.54-$1.57 and the consensus of $1.57. Hologic... More
